Related Experiment Video

Updated: Jul 4, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

336

Antibiotic Resistance of Helicobacter pylori: Mechanisms and Clinical Implications

Md Hasanuzzaman1, Chang Seok Bang1, Eun Jeong Gong2

  • 1Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.

Journal of Korean Medical Science
|January 30, 2024
PubMed

Insights

Antibiotic resistance in Helicobacter pylori is a growing problem, complicating treatment for gastrointestinal diseases. This review examines resistance mechanisms and strategies to overcome them, aiming for better patient outcomes.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Helicobacter pylori is a major cause of gastrointestinal diseases like ulcers and gastric cancer.
  • Increasing antibiotic resistance in H. pylori complicates treatment.
  • Multidrug-resistant strains present significant therapeutic challenges.

Purpose of the Study:

  • To review the mechanisms of H. pylori antibiotic resistance.
  • To discuss the clinical implications of this resistance.
  • To explore strategies for overcoming H. pylori antibiotic resistance.

Main Methods:

  • Literature review of studies on H. pylori antibiotic resistance.
  • Analysis of mechanisms of resistance to common antibiotics.
  • Evaluation of clinical data on treatment outcomes.
  • Synthesis of current and emerging strategies to combat resistance.

Main Results:

  • H. pylori exhibits resistance to multiple antibiotics, driven by specific genetic mutations and efflux pumps.
  • Antibiotic resistance leads to higher rates of treatment failure and disease progression.
  • Emerging resistance necessitates novel therapeutic approaches.

Conclusions:

  • Understanding resistance mechanisms is key to developing effective treatment strategies.
  • Combating H. pylori antibiotic resistance requires a multifaceted approach, including new drugs and combination therapies.
  • Continued research is vital to address the evolving challenge of H. pylori infections.
Keywords:
Antibiotic ResistanceAntimicrobial StewardshipHelicobacter pyloriMultidrug Resistance

More Related Videos

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

3.3K
Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

291

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
407
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
430
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
124
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
427
Antibiotic Selection00:57

Antibiotic Selection

Overview
53.6K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
327